Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
ACCELERON PHARMA INC (XLRN) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/02/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
11/24/2021 SC 13D/A Avoro Capital Advisors LLC reports a 0% stake in Acceleron Pharma Inc.
11/22/2021 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ACCELERON PHARMA INC.",
"."
11/22/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
11/22/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/22/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/17/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/17/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/17/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/12/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/10/2021 SC 13G/A FMR LLC reports a 0.8% stake in ACCELERON PHARMA INC
11/10/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/08/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
11/08/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
11/04/2021 10-Q Quarterly Report for the period ended September 30, 2021
11/04/2021 8-K Quarterly results
Docs: "Acceleron Reports Third Quarter 2021 Financial Results - Acceleron recognized approximately $32.0 million in royalty revenue for Q3 2021 from approximately $160 million in net sales of REBLOZYL® -"
10/29/2021 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
10/29/2021 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
10/28/2021 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/27/2021 8-K Results of Operations and Financial Condition  Interactive Data
10/20/2021 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/13/2021 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/12/2021 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
10/12/2021 SC TO-T Form SC TO-T - Tender offer statement by Third Party:
10/05/2021 SC 13D Avoro Capital Advisors LLC reports a 7.3% stake in Acceleron Pharma Inc.
10/01/2021 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
09/30/2021 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party:
09/30/2021 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
09/30/2021 SC14D9C Form SC14D9C - Written communication relating to third party tender offer:
09/30/2021 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "AGREEMENT AND PLAN OF MERGER",
"Merck to Acquire Acceleron Pharma Inc."
08/05/2021 10-Q Quarterly Report for the period ended June 30, 2021
08/05/2021 8-K Quarterly results
07/28/2021 8-K Results of Operations and Financial Condition  Interactive Data
06/22/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy